Ann: Paradigm AGM Presentation, page-122

First 122 Last

Share
Profile

Follow
hercules007

4,525 Posts.

110

05/12/22

17:11

Post #: 65159727
Share

Originally posted by Mozzarc: ↑

Hi Babba,

In this case I'm more guided by what was said in the AGM. My understanding is that she indeed consults for us and that's a very very impressive thing in itself. I will have more to say (post!) on this but I'm fairly certain she would be guiding us or would have guided us in a few areas relating to our trial/studies to date.

From an advocate point of view, as Paul mentioned:

"...she helped us with the assays for many of the biomarkers."

He went on to say wording around that both of these consultant (Dr Virginia and Dr Stefan) are both working diligently to ensure they have the necessary data to convince regulatory authorities that these biomarkers are real.

I think that in itself implies a degree of advocacy, at least in the sense that they are waiting for further data from PAR (6 month, 12 month).

He also stated "...Virginia has been a tremendous benefit to our company as has Stefan Lohmander..."

"We sent our data to Virginia and her comment was like wow this is amazing and she wanted to know more", he then even stated that she would be an author on the paper.

Yeah thats kinda smelling/feeling like advocacy. I'm trying to be more on the conservative side here as others have mentioned, things can take longer than we wish, that's the nature of the beast...I think we will understand a lot more in Q1 at 6 month data release.

We have all witnessed our SP getting nice lifts in the past only to fall back and while this could happen again in the future, I wonder if the news on 6 month will be pivotal and while it may cause us to come back down again, it will be at least be to a higher base compared to pre-news?

As I often say to my friend the Anchor Man, we are early to this. We wonder how is that possible, how can we be early when we have been in this for years, its evidenced by another little story today. I wont name names to protect the innocent (guilty!) but I called a friend's husband and spoke to him for the first time, he is in the broker fraternity and has had some experience in this line...he did not know about PAR. If he doesn't, how can we expect the average Joe to?

We have been following this for some time, the world has no clue about us. This will change.

Hope that helps.

Mozz

Expand

A big majority of the broker people would not veer off what the house published research papers cover, so it would be an exception if a broker happens to know PAR.

PAR Price at posting: $1.46 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

JBY

James Bay latest lithium player to pivot to other metals amidst lithium slump

BM8

Battery Age Minerals gets set to capitalise on critical mineral demand

ASX Market Update: Index pulls back from record highs | October 16, 2024

PME

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

There are more pages in this discussion • 20 more messages in this thread...

First 122 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 20.5¢		Change 0.005(2.50%)		Mkt cap ! $71.79M

Open	High	Low	Value	Volume
20.5¢	20.5¢	19.5¢	$203.7K	1.013M

Buyers (Bids)

No.	Vol.	Price($)
2	21749	20.5¢

Sellers (Offers)

Price($)	Vol.	No.
21.0¢	24639	2

View Market Depth

No.	Vol.	Price($)
1	10000	0.205
3	87500	0.200
12	219273	0.195
20	394741	0.190
6	133102	0.185

Price($)	Vol.	No.
0.210	24639	2
0.215	88520	10
0.220	63781	4
0.225	331452	6
0.230	73195	5

Last trade - 16.10pm 16/10/2024 (20 minute delay)

PAR (ASX) Chart

Ann: Paradigm AGM Presentation, page-122

James Bay latest lithium player to pivot to other metals amidst lithium slump

Battery Age Minerals gets set to capitalise on critical mineral demand

ASX Market Update: Index pulls back from record highs | October 16, 2024

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Paradigm AGM Presentation, page-122

Top Stories

James Bay latest lithium player to pivot to other metals amidst lithium slump

Battery Age Minerals gets set to capitalise on critical mineral demand

ASX Market Update: Index pulls back from record highs | October 16, 2024

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News